WA
WestEnd Advisors Portfolio holdings
AUM
$4.03B
This Quarter Return
+5.61%
1 Year Return
+16.84%
3 Year Return
+52.53%
5 Year Return
+81.57%
10 Year Return
+163.89%
AUM
$3.68B
AUM Growth
+$3.68B
(-100%)
Cap. Flow
+$3.68B
Cap. Flow
% of AUM
100%
Top 10 Holdings %
Top 10 Hldgs %
66.15%
Holding
394
New
387
Increased
–
Reduced
–
Closed
–
Top Buys
Top Sells
| 1 |
WisdomTree Emerging Markets High Dividend Fund
DEM
|
$3.53M |
| 2 |
Whirlpool
WHR
|
$203K |
| 3 |
Jack Henry & Associates
JKHY
|
$164K |
| 4 |
DaVita
DVA
|
$116K |
| 5 |
Western Union
WU
|
$60K |
Sector Composition
| 1 | Financials | 7.27% |
| 2 | Consumer Discretionary | 4.37% |
| 3 | Technology | 4.27% |
| 4 | Communication Services | 3.81% |
| 5 | Healthcare | 3.78% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
101
Starbucks
SBUX
$99.2B
| $1.17K | ﹤0.01% |
+10
| New | +$1.17K |
|
102
Advanced Micro Devices
AMD
$263B
| $1.15K | ﹤0.01% |
+8
| New | +$1.15K |
|
103
Texas Instruments
TXN
$178B
| $1.13K | ﹤0.01% |
+6
| New | +$1.13K |
|
104
Intuitive Surgical
ISRG
$158B
| $1.08K | ﹤0.01% |
+3
| New | +$1.08K |
|
105
Bristol-Myers Squibb
BMY
$96.7B
| $1.06K | ﹤0.01% |
+17
| New | +$1.06K |
|
106
Marsh & McLennan
MMC
$101B
| $1.04K | ﹤0.01% |
+6
| New | +$1.04K |
|
107
CVS Health
CVS
$93B
| $1.03K | ﹤0.01% |
+10
| New | +$1.03K |
|
108
Zoetis
ZTS
$67.6B
| $976 | ﹤0.01% |
+4
| New | +$976 |
|
109
Chubb
CB
$111B
| $966 | ﹤0.01% |
+5
| New | +$966 |
|
110
Oracle
ORCL
$628B
| $959 | ﹤0.01% |
+11
| New | +$959 |
|
111
Intercontinental Exchange
ICE
$100B
| $957 | ﹤0.01% |
+7
| New | +$957 |
|
112
Applied Materials
AMAT
$124B
| $944 | ﹤0.01% |
+6
| New | +$944 |
|
113
Truist Financial
TFC
$59.8B
| $936 | ﹤0.01% |
+16
| New | +$936 |
|
114
Elevance Health
ELV
$72.4B
| $927 | ﹤0.01% |
+2
| New | +$927 |
|
115
Target
TGT
$42B
| $925 | ﹤0.01% |
+4
| New | +$925 |
|
116
CME Group
CME
$97.1B
| $913 | ﹤0.01% |
+4
| New | +$913 |
|
117
Aon
AON
$80.6B
| $901 | ﹤0.01% |
+3
| New | +$901 |
|
118
Amgen
AMGN
$153B
| $899 | ﹤0.01% |
+4
| New | +$899 |
|
119
US Bancorp
USB
$75.5B
| $898 | ﹤0.01% |
+16
| New | +$898 |
|
120
Stryker
SYK
$149B
| $802 | ﹤0.01% |
+3
| New | +$802 |
|
121
IBM
IBM
$227B
| $801 | ﹤0.01% |
+6
| New | +$801 |
|
122
Moody's
MCO
$89B
| $781 | ﹤0.01% |
+2
| New | +$781 |
|
123
Moderna
MRNA
$9.36B
| $761 | ﹤0.01% |
+3
| New | +$761 |
|
124
Automatic Data Processing
ADP
$121B
| $739 | ﹤0.01% |
+3
| New | +$739 |
|
125
Gilead Sciences
GILD
$140B
| $726 | ﹤0.01% |
+10
| New | +$726 |
|